Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3β

Journal of Bone and Mineral Research

Volumn 19, Issue 11, 2004, Pages 1892-1904

  Ziros, Panos G ^a   Georgakopoulos, Tassos ^a   Habeos, Ioannis ^a   Basdra, Efthimia K ^b   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Growth hormone; Osteoblast; Protein protein interaction; Runx2 Cbfa1; Stat3

Indexed keywords

GROWTH HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; PLEIOTROPHIN; STAT 3 BETA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; GLUTATHIONE TRANSFERASE; LUCIFERASE; MILK PROTEIN; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN; TYROSINE;

ARTICLE; CELL FUNCTION; CELL STRAIN; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; GROWTH HORMONE RELEASE; HUMAN; HUMAN CELL; HYBRID; IMMUNOPRECIPITATION; OSTEOBLAST; PROMOTER REGION; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; BONE; CELL DIFFERENTIATION; CELL NUCLEUS; CHEMISTRY; DOSE RESPONSE; GENETIC TRANSCRIPTION; HELA CELL; KINETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PLASMID; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; TWO HYBRID SYSTEM;

BLOTTING, WESTERN; BONE AND BONES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GLUTATHIONE TRANSFERASE; GROWTH HORMONE; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; KINETICS; LUCIFERASES; MAP KINASE SIGNALING SYSTEM; MILK PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; OSTEOBLASTS; PHOSPHORYLATION; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES; TYROSINE;

EID: 16244393552     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.040701     Document Type: Article

References (67)

1. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC 1998 Growth hormone and bone. Endocr Rev 19:55-79.
2. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C 1993 Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244.
3. Herrington J, Smit LS, Schwartz J, Carter-Su C 2000 The role of STAT proteins in growth hormone signalling. Oncogene 19:2585-2597.
4. Zhu T, Goh EL, Graichen R, Ling L, Lobie PE 2001 Signal transduction via the growth hormone receptor. Cell Signal 13:599-616.
5. Carter-Su C, King AP, Argetsinger LS, Smit LS, Vanderkuur J, Campbell GS 1996 Signalling pathway of GH. Endocr J 43(Suppl):S65-S70.
6. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL 2001 Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276:14443-14450.
7. Huang Z, Cheng SL, Slatopolsky E 2001 Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation. J Biol Chem 276:21351-21358.
8. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
9. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B 2002 The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
10. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
11. Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, Nakatsuka M 1999 Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274:6972-6978.
12. Jimenez MJ, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C 1999 Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19:4431-4442.
13. Ziros PG, Rojas Gil A-P, Georgakopoulos T, Habeos I, Kletsas D, Basdra EK, Papavassiliou AG 2002 The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J Biol Chem 277:23934-23941.
14. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R 2001 TGF-β-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 9:2254-2272.
15. Franceschi RT, Xiao G 2003 Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446-454.
16. Hanai JI, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo W-H, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, Stavnezer J, Kawabata M, Miyazono K, Ito Y 1999 Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Cα promoter. J Biol Chem 274:31577-31582.
17. Alonzo R, Selvamurugan N, Karsenty G, Partridge NC 2002 Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J Biol Chem 277:816-822.
18. Nilsson A, Swolin D, Enerback S, Ohlsson C 1995 Expression of functional growth hormone receptors in cultured human osteoblast-like cells. J Clin Endocrinol Metab 80:3483-3488.
19. Morales O, Lindgren U, Haldosen LA 2000 Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells. J Bone Miner Res 15:2284-2290.
20. Gerland K, Bataille-Simoneau N, Basle M, Fourcin M, Gascan H, Mercier L 2000 Activation of the Jak/Stat signal transduction pathway in GH-treated rat osteoblast-like cells in culture. Mol Cell Endocrinol 168:1-9.
21. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K 2000 Current Protocols in Molecular Biology. Greene Publishing Associates & Wiley-Interscience, New York, NY, USA.
22. James P, Halladay J, Craig EA 1996 Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144:425-436.
23. Georgakopoulos T, Koutroubas G, Vakonakis I, Tzermia M, Prokova V, Voutsina A, Alexandraki D 2001 Functional analysis of the Saccharomyces cerevisiae YFR021w/YGR223c/YPL100w ORF family suggests relations to mitochondrial/peroxisomal functions and amino acid signalling pathways. Yeast 18:1155-1171.
24. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A, Li Y, Godwin B, Conover D, Kalbfleisch T, Vijayadamodar G, Yang M, Johnston M, Fields S, Rothberg JM 2000 A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403:623-627.
25. Muhlrad D, Hunter R, Parker R 1992 A rapid method for localized mutagenesis of yeast genes. Yeast 8:79-82.
26. Ducy P, Karsenty G 1995 Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869.
27. Wagner BJ, Hayes TE, Hoban CJ, Cochran BH 1990 The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 9:4477-4484.
28. Wakao H, Gouilleux F, Groner B 1994 Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 13:2182-2191.
29. Devine JH, Eubank DW, Clouthier DE, Tontonoz P, Spiegelman BM, Hammer RE, Beale EG 1999 Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor gamma and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J Biol Chem 274:13604-13612.
30. Roupas P, Herington AC 1989 Cellular mechanisms in the processing of growth hormone and its receptor. Mol Cell Endocrinol 61:1-12.
31. Zhang Y, Guan R, Jiang J, Kopchick JJ, Black RA, Baumann G, Frank SJ 2001 Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis. J Biol Chem 276:24565-24573.
32. Hipskind RA, Bilbe GM 1998 AP kinase signaling cascades and gene expression in osteoblasts. Front Biosci 3:DS04-D816.
33. Lou J, Tu Y, Li S, Manske PR 2000 Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun 268:757-762.
34. Scheven BA, Hamilton NJ, Fakkeldij TM, Duursma SA 1991 Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regul 1:160-167.
35. Saggese G, Federico G, Cinquanta L 1993 In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast-like cells. Acta Paediatr Suppl 82(Suppl 391):54-59.
36. Takahashi MO, Takahashi Y, Iida K, Okimura Y, Kaji H, Abe H, Chihara K 1999 Growth hormone stimulates tyrosine phosphorylation of focal adhesion kinase (p125(FAK)) and actin stress fiber formation in human osteoblast-like cells, Saos2. Biochem Biophys Res Commun 263:100-106.
37. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT 2000 MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor Cbfal. J Biol Chem 275:4453-4459.
38. Kim S, Koga T, Isobe M, Kern BE, Yokochi T, Chin YE, Karsenty G, Taniguchi T, Takayanagi H 2003 Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 17:1979-1991.
39. Yoshida CA, Furuichi T, Fujita T, Fukuyama R, Kanatani N, Kobayashi S, Satake M, Takada K, Komori T 2002 Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 32:633-638.
40. Kundu M, Javed A, Jeon JP, Horner A, Shum L, Eckhaus M, Muenke M, Lian JB, Yang Y, Nuckolls GH, Stein GS, Liu PP 2002 Cbfβ interacts with Runx2 and has a critical role in bone development. Nat Genet 32:639-644.
41. Lai CF, Ripperger J, Morella KK, Wang Y, Gearing DP, Horseman ND, Campos SP, Fey GH, Baumann H 1995 STAT3 and STAT5B are targets of two different signal pathways activated by hematopoietin receptors and control transcription via separate cytokine response elements. J Biol Chem 270:23254-23257.
42. Caldenhoven E, Dijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers JWJ, Koenderman L, Groot RP 1996 STAT3β, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 271:13221-13227.
43. Schaefer TS, Sanders LK, Nathans D 1995 Cooperative transcriptional activity of Jun and Stat3β, a short form of Stat3. Proc Natl Acad Sci USA 92:9097-9101.
44. Schaefer TS, Sanders LK, Park OK, Nathans D 1997 Functional differences between STAT3α and STAT3β. Mol Cell Biol 17:5307-5316.
45. Morales O, Faulds MH, Lindgren UJ, Haldosen LA 2002 1α,25- dihydroxyvitamin D3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells. J Biol Chem 277:34879-34884.
46. Anderson N 1992 Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes. Biochem J 284:649-652.
47. Campbell G, Pang L, Miyasaka T, Saltiel A, Carter-Su C 1992 Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts. J Biol Chem 267:6074-6080.
48. Love DW, Whatmore AJ, Clayton PE, Silva CM 1998 Growth hormone stimulation of the mitogen-activated protein kinase pathway is cell type specific. Endocrinology 139:1965-1971.
49. Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC 2003 Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111:1651-1664.
50. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT 2002 Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 17:101-110.
51. Mathov I, Plotkin LI, Sgarlata CL, Leoni J, Bellido T 2001 Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro. J Bone Miner Res 16:2050-2056.
52. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT 2002 Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277:36181-36187.
53. Wang FS, Wang CJ, Sheen-Chen SM, Kuo YR, Chen RF, Yang KD 2002 Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors. J Biol Chem 277:10931-10937.
54. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamagushi A, Komori T 2001 Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 155:157-166.
55. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P 2002 High bone resorption in adult aging transgenic mice overexpressing Cbfa1/Runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22:6222-6233.
56. Ohlsson C, Bengtsson BA, Johannsson G 2000 GH and bone - experimental and clinical studies. Endocr J 47(Suppl):S9-S16.
57. Haase HR, Ivanovski S, Waters MJ, Bartold PM 2003 Growth hormone regulates osteogenic marker mRNA expression in human periodontal fibroblasts and alveolar bone-derived cells. J Periodontal Res 38:366-374.
58. Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA 2000 Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 106:1095-1103.
59. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL 2002 Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012.
60. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA, Clemens TL 2000 Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674-2682.
61. Zaidi SK, Javed A, Choi JY, van Wijnen AJ, Stein JL, Lian JB, Stein GS 2001 A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J Cell Sci 114:3093-3102.
62. Zeng C, McNeil S, Pockwinse S, Nickerson J, Shopland L, Lawrence JB, Penman S, Hiebert S, Lian JB, van Wijnen AJ, Stein JL, Stein GS 1998 Intranuclear targeting of AML/CBF regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci USA 95:1585-1589.
63. Westendorf JJ, Zaidi SK, Cascino JE, Kahler R, van Wijnen AJ, Lian JB, Yoshida M, Stein GS, Li X 2002 Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol Cell Biol 22:7982-7992.
64. Zeng C, van Wijnen AJ, Stein JL, Meyers S, Sun W, Shopland L, Lawrence JB, Penman S, Lian JB, Stein GS, Hiebert SW 1997 Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF transcription factors. Proc Natl Acad Sci USA 94:6746-6751.
65. Zaidi SK, Sullivan AJ, van Wijnen AJ, Stein JL, Stein GS, Lian JB 2002 Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci USA 99:8048-8053.
66. Zaidi SK, Sullivan AJ, Medina R, Ito Y, Van Wijnen AJ, Stein JL, Lian JB, Stein GS 2004 Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J 23:790-799.
67. Foley HA, Ofori-Acquah SF, Yoshimura A, Critz S, Baliga BS, Pace BS 2002 Stat3 beta inhibits gamma-globin gene expression in erythroid cells. J Biol Chem 277:16211-16219.